Dr. Ole Dammann

Springboard Health Angels is a Berlin-based business angel group that invests in early-stage life sciences startups, with a focus on health tech

iduneo transforms clinical trial recruitment in Oncology through two powerful channels: direct patient engagement and seamless hospital network integration. Our AI-driven platform precisely qualifies patients for trials, automating the complex screening and referral process while integrating directly into clinical workflows.

Springboard Health Angels is a Berlin-based business angel group that invests in early-stage life sciences startups, with a focus on health tech

Pratia is a Research Site Network with 90+ Centers across 6 countries in Europe. With 700+ Clinical Trials carried out since 2012, Pratia brings Tech-savvy, adaptable solutions in innovative treatments at your convenience. It is a Platform for innovative medicine, which offers the best mix of Sites, expertise, access to Patients to each protocol, as well as close collaboration with the local healthcare systems. Pratia can address the dynamically changing requirements in the industry, including Remote Monitoring and Decentralized Studies. In 2014 Pratia joined Neuca Plc. - the leading organization in the Pharmaceutical Wholesaling and the Healthcare Industry.

At Startupbootcamp, we supercharge startup growth – providing capital, world-class mentorship, and direct access to investors, corporate partners, and industry experts. 🚀 1,700+ startups backed: $2B+ raised, 75% still scaling 🌍 30+ innovation ecosystems under management 100+ events per year | 150+ accelerators in 15+ countries Our mission: Accelerate 100,000 impact-driven startups in the next decade – shaping the future and driving real change toward the UN’s Sustainable Development Goals. Beyond accelerators, we empower businesses and governments to create, scale, and manage innovation ecosystems – from long-term innovation strategies to disruptive business models and breakthrough product innovations. We build the infrastructure that connects startups, corporates, and investors to turn innovation into real impact. ⚡ Join the Startupbootcamp ecosystem & shape the future. More information: www.startupbootcamp.org

kfbg is the holding of kfgn, a group of seven sites across Germany working in the field of clinical research with a central management & services organization as central point of contact. kfgn is dedicated to conduct clinical trials and is recognized as preferred partner of patients and the pharmaceutical industry. About 80 people experienced and qualified investigational staff, PIs with experience in the major therapeutic areas, study coordinators and quality assurance colleagues focus on the quality of patient care and trial outcomes. Established in 1995 kfgn calls on more than 20 years of experience in clinical research audited by various regulatory authorities such as the FDA, the Japanese health authorities as well as the German Institute for Drugs and Medical Devices - BfArM. With more than 30.000 randomized patients kfgn constantly contributes -with always new approaches- to the advance in health care making new therapies safer and faster available for patients. As a holding kfbg is continuously looking for opportunities to further develop the business of the group in existing and related areas. Together with its co-operation partners kfbg is driving the digitalization of clinical research and thus the future of medicine in general. Its digital focus is TO INCREASE ((on the rise of)) data quality, a transparent documentation and efficient patient recruitment. Due to its expertise in clinical research kfbg is also a partner for the joint development of digital therapeutic solutions and innovative medical devices. kfbg helps to define the therapeutic use and provide an evidence-based validation of the concept. On the basis of clinical testing with carefully selected patient groups the relevant data is generated for a successful market positioning.